Margin dodolan operasi Annexon, Inc. (ANNX)

Simbol lan logo merek annexonbio.com (ANNX)

Amidst the fierce competition among biotech firms for leadership in complement therapy, the operating margin has become a key benchmark. The 0.00 metric reflects the latest value, providing a real-time assessment of the financial stability of Annexon, Inc. (ANNX). The company leverages a strong academic research staff and is focusing its resources on completing the final trials of the drug ANX005 for the treatment of Guillain-Barré syndrome.

ANNX: Margin operasi Annexon 04.07.2022 - 19.11.2026

Rincian analitis perusahaan Annexon (ANNX)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:ANNX, Annexon, Inc.
Barang utama annexonbio.com

The efficiency of Annexon, Inc. (ANNX) is driven by its ability to minimize capital expenditures through the outsourcing of production and testing. Operating margin is calculated as the ratio of operating profit to total revenue, reflecting the net profitability of the core business. Investors utilize this metric to identify hidden degradation in profitability before a decline in share prices. An analysis of the average monthly operating margin allows for an assessment of the stability of the asset-light model. The trend in this average monthly operating margin confirms the actual financial strength of the company.

Perusahaan pesaing

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|Rentabilitas dodolan operasi prothena.com|Alector Therapeutics (ALEC) - Rentabilitas operasi|Margin dodolan operasi Omeros Corp|Margin dodolan operasi NGNE|ACIU: Tingkat bathi operasi|Margin dodolan operasi VYGR (Voyager Corp)|Margin dodolan operasi Neumora NMRA|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi